Welcome to the Sanofi Media Room

Our Media Room is designed to provide reporters with company and product news, as well as key facts, figures and background information.  To help you keep up with the latest news, we offer email alerts and RSS feeds.  If you are a reporter and have questions about the company or our products, visit the Media Contacts page.

Press Releases
Jun 10, 2021

Inaugural Sanofi Biogenius Grant awarded to four diverse secondary schools across Canada to revitalize science education for their students. Driving towards Science, Technology, Engineering &...

Jun 1, 2021

DUPIXENT® is the only biologic medicine approved by Health Canada to treat moderate-to-severe atopic dermatitis (AD). Public reimbursement under the Régie de l'assurance maladie du Québec will...

May 25, 2021

* DUPIXENT® is the only biologic medicine approved by Health Canada to treat moderate-to-severe atopic dermatitis. * Public reimbursement under the Ontario Exceptional Access Program and the New...

More »

Stay Updated
* Required Fields